维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Akcakanat"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Open-label random-ized clinical trial of standard neoadjuvant chemothera- py with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with tri- ple receptor-negative breast caneer显示文摘	Gonzalez-Angulo AM Akcakanat A Liu S	2014	Ann Oneol2014，25，6：	1
2	Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors显示文摘	Moreno A Akcakanat A Munsell MF	2008	Endocr Relat Cancer2008，15，：	1
3	Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy 显示文摘	Akcakanat A Kanda T Tanabe T	2006	Int J Cancer2006，118，1：	1
4	Biomarkers of res- ponse to Akt inhibitor MK-2206 in breast cancer显示文摘	Sangai T Akcakanat A Chen H	2012	Clin Cancer Res2012，18，20：	1
5	NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer显示文摘	Argun Akcakanat Tatsuo Kanda Yu Koyama Michitoshi Watanabe Eiji Kimura Yutaka Yoshida Shintarou Komukai Satoru Nakagawa Shoji Odani Hiroshi Fujii Katsuyoshi Hatakeyama	2004	Cancer Chemotherapy and Pharmacology2004，，1：	1
6	Targeting the PI3- kinase/Akt/mTOR signaling pathway显示文摘	Hassan B Akcakanat A Holder AM	2013	Surg Oncol Clin N Am2013，22，4：	1
7	Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer 显示文摘	LUYIMBAZI D AKCAKANAT A MCAULIFFE P F	2010	Molecular Cancer Therapeutics2010，9，0：	1
8	PIK3CA/ PTEN mutations and Akt activation as markers of sensitivity to al- losteric roTOR inhibitors 显示文摘	Meric-Bemstam F Akcakanat A Chen H	2012	Clin Cancer Res2012，18，6：	1
9	EIF4E knockdown decreases breast cancer cell growth without activating Akt signaling显示文摘	SONI A AKCAKANAT A SINGH G	2008	Mol Cancer Ther2008，7，7：	1
10	Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors显示文摘	Moreno A Akcakanat A Munsell MF		0，，01：	1
11	Targeting the PI3-kinase/Akt/mTOR signaling pathway 显示文摘	HASSAN B AKCAKANAT A HOLDER A M	2013	Surg Oncol Clin North Am2013，22，4：	1
12	eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling 显示文摘	Soni A Akcakanat A Singh G Luyimbazil D Zheng Y Kiml D	2008	Mol Cancer Ther2008，7，7：	1
13	eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling显示文摘	Soni A Akcakanat A Singh G et a1	2008	Mol Cancer Ther2008，7，7：	1
14	Open- labd randomized clinical trail of standard neoadjuvant che- motherpay with paclitaxel follwed by fec versue the combination of paclitaxel and everolimus followed by fec in women with triple receptor-negative breast cancer 显示文摘	Gonzalez-angulo AM Akcakanat A Liu S	2014	Annals of Oncology2014，25，6：	1
15	Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases显示文摘	Akcakanat A Sahin A Shaye AN	2008	Cancer2008，112，11：	1
16	Regulation and localization of ribosomal protein $6 kinase 1 isoforms 显示文摘	Kim D Akcakanat A Singh G	2009	Growth Factors2009，27，1：	1
17	Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer显示文摘	Luyimbazi D Akcakanat A Mcauliffe PF	2010	Mol Cancer Ther2010，9，10：	1
18	Comparison of Akt/mTOR signaling in pri- mary breast tumors and matched distant metastases显示文摘	Akcakanat A Sahin A Shaye AN	2008	Cancer2008，112，：	1
19	PIK3CA/PTEN mutations and Akt activation as markers of sensitivity toallosteric mTOR inhibitors 显示文摘	Meric-Bernstam F Akcakanat A* Chen H*	2012	Clinical cancer research2012，18，6：	1
20	The rapamycin-regulated gene ex- pression signature determines prognosis for breast cancer 显示文摘	Akcakanat A Zhang L Tsavachidis S	2009	Mol Cancer2009，8，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示